The company traded up yesterday 0.62 percent and hit $117.63 on 251,801 shares.
Here are six key notes, according to the report:
1. Argus updated the price from $166 to $135 yesterday.
2. Argus currently has a “buy” rating on Zimmer stock.
3. Jeffries Group upgraded Zimmer from a “hold” to a “buy” and raised their price from $119 to $131.
4. Deutsche Bank analyst raised their price target on Zimmer from $107 to $114 and gave the company a “hold” rating on Feb. 2.
5. Canaccord Genuity raised the price target from $130 to $150 on Jan. 30.
6. Robert W. Baird upgraded from “neutral” rating on the shares to “outperform” and raised the price target from $110 to $125.
More articles on orthopedic devices:
7 key trends in joint replacement customization
Amedica files FDA application for spinal implant spacers with porous silicon nitride center—6 things to know
Smith & Nephew launches new suture anchor
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
